Macrocycles in Drug Discovery
Jeremy Levin
10/2014 · Drug Discovery Series 40. kniha · Royal Society of Chemistry
E‑kniha
528
Počet strán
reportHodnotenia a recenzie nie sú overené Ďalšie informácie
Táto e‑kniha
This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
O autorovi
Jeremy Levin is currently a Director of Medicinal Chemistry at Boehringer Ingelheim Pharmaceuticals, with a total of 25 years of experience in the pharmaceutical industry. He has worked in multiple therapeutic areas, including CNS, inflammation and immunology, and oncology. Dr Levin has authored or co-authored more than 70 papers in peer reviewed journals and served as an inventor on more than 60 issued U.S patents.
Ohodnoťte túto elektronickú knihu
Povedzte nám svoj názor.
Informácie o dostupnosti
Smartfóny a tablety
Nainštalujte si aplikáciu Knihy Google Play pre Android a iPad/iPhone. Automaticky sa synchronizuje s vaším účtom a umožňuje čítať online aj offline, nech už ste kdekoľvek.
Laptopy a počítače
Audioknihy zakúpené v službe Google Play môžete počúvať prostredníctvom webového prehliadača v počítači.
Čítačky elektronických kníh a ďalšie zariadenia
Ak chcete tento obsah čítať v zariadeniach využívajúcich elektronický atrament, ako sú čítačky e‑kníh Kobo, musíte stiahnuť príslušný súbor a preniesť ho do svojho zariadenia. Pri prenose súborov do podporovaných čítačiek e‑kníh postupujte podľa podrobných pokynov v centre pomoci.
